Keyphrases
Risk Score
100%
Heart Failure
100%
Newly Diagnosed
100%
Population Cohort Study
100%
Renal Function Improvement
100%
Incident Heart Failure
55%
Area under the Curve
44%
Heart Failure with Preserved Ejection Fraction (HFpEF)
33%
Heart Disease Diagnosis
33%
Patients with Heart Failure
22%
Scotland
11%
Tayside
11%
Population-based
11%
Renal Function
11%
Dialysis
11%
Kidney Transplantation
11%
Outcome Prediction
11%
Strong Predictor
11%
Ejection Fraction
11%
Longitudinal Cohort
11%
Disease Trajectory
11%
Discrimination Power
11%
Heart Failure Therapy
11%
Disease-modifying Therapy
11%
End-stage Kidney Disease
11%
Guideline-directed Medical Therapy
11%
Renal Decline
11%
NELSON
11%
Composite Events
11%
Cardiorenal Outcomes
11%
Cardiovascular Pharmacotherapy
11%
Medicine and Dentistry
Cohort Analysis
100%
Kidney Function
100%
Congestive Heart Failure
100%
Diseases
14%
Combination Therapy
7%
Cardiovascular System
7%
Drug Therapy
7%
Ejection Fraction
7%
End Stage Renal Disease
7%
Kidney Transplantation
7%
Heart Failure with Reduced Ejection Fraction
7%
Biochemistry, Genetics and Molecular Biology
Cohort Study
100%
Kidney Function
100%
Heart Ejection Fraction
50%
Drug Therapy
50%
Nursing and Health Professions
Cohort Analysis
100%
Congestive Heart Failure
100%
Area under the Curve
28%
Diseases
14%
Practice Guideline
7%
Combination Therapy
7%
Drug Therapy
7%
Heart Ejection Fraction
7%
End Stage Renal Disease
7%
Heart Failure with Reduced Ejection Fraction
7%
Kidney Transplantation
7%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Congestive Heart Failure
100%
Diseases
14%
Pharmacotherapy
7%
Combination Therapy
7%
End Stage Renal Disease
7%
Heart Failure with Reduced Ejection Fraction
7%